IMNM

ImmunomeD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

IMNM vs peer average

34/100

IMNM vs. peer average (D vs. C)

Grade spread

B 3 · C 4 · D 1 · F 1

Graded peers loaded

Coverage

9 graded

100% of tracked

Peer overview

CLDX is the first available peer comparator.

Celldex is the closest candidate in the provided set for a development-stage biotech valuation comparison: event-driven, cash-burn funded and reliant on clinical execution, though it is not a direct desmoid or ADC peer.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerCLDXCelldex Therapeutics

IMNM

Immunome

CLDX

Celldex Therapeutics

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Defensive

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs CLDX

IMNM / CLDX

Grade Position

Below peers

IMNM vs. peer average (D vs. C)

34/100

Momentum

CLDX

Value

IMNM

Sentiment

CLDX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs IMNM

CLDX

60/100

-1

IRON

60/100

-1

PBH

Prestige Consumer Healthcare Inc Common

20/100

ELVN

Enliven Therapeutics Inc Common

80/100

-2

RARE

Ultragenyx Pharmaceutical Inc Common

60/100

-1

CLDX is the first peer returned for this comparison set.